Search - tctmd.com

Displaying 221 - 240 of 500

Sort: Relevancy | Date

News Opinion Off Script

Off Script: Black Lives, COVID-19, Katrina, and Social Justice—Time for Healers to Step Up

Keith C. Ferdinand

June 02, 2020

News Daily News

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

Michael O'Riordan

May 29, 2020

News Daily News

US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable

Shelley Wood

May 29, 2020

News Daily News

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Yael L. Maxwell

May 28, 2020

News Daily News

Survey: Interventional Fellows Fear Missing Competency Goals Due to COVID-19

Yael L. Maxwell

May 22, 2020

News Features

Cardiology After COVID-19: Physicians Predict Lasting Change

Yael L. Maxwell

May 20, 2020

News Daily News

COVID-19 in NYC: CV Risk Factors and Bleak Outcomes in the Critically Ill

Michael O'Riordan

May 19, 2020

News Daily News

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

Michael O'Riordan

May 15, 2020

News Daily News

Takotsubo Rising During COVID-19? Stress, Viral Triggers Need Attention

Yael L. Maxwell

May 08, 2020

News Daily News

Infection Risk No Higher With Recycled Pacemakers, Defibrillators

L.A. McKeown

May 07, 2020

News Daily News

COVID-19: TCTMD’s Daily Dispatch for May

Todd Neale

May 01, 2020

News Features

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

Shelley Wood

April 29, 2020

News Daily News

COVID-19’s Lopsided Impact on Minorities Should ‘Ignite’ Reform, Experts Say

Yael L. Maxwell

April 20, 2020

News Daily News

COVID-19 Linked to 38% Drop in US STEMIs

Shelley Wood

April 10, 2020

News Daily News

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

Caitlin E. Cox

April 09, 2020

News Conference News ACC 2020

Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH

Yael L. Maxwell

April 06, 2020

News Features

The Mystery of the Missing STEMIs During the COVID-19 Pandemic

Shelley Wood

April 02, 2020

Hope for these hard-to-treat patients: more than half saw ≥ 50% decrease at 24 weeks, regardless of LDL receptor function.

News Conference News ACC 2020

Evinacumab Cuts LDL Cholesterol in Homozygous FH

Yael L. Maxwell

April 01, 2020

News Daily News

Inclisiran Data in NEJM Prompt Talk of What Comes Next

Caitlin E. Cox

March 24, 2020

Advertisement

Off Script: Black Lives, COVID-19, Katrina, and Social Justice—Time for Healers to Step Up

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Survey: Interventional Fellows Fear Missing Competency Goals Due to COVID-19

Cardiology After COVID-19: Physicians Predict Lasting Change

COVID-19 in NYC: CV Risk Factors and Bleak Outcomes in the Critically Ill

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

Takotsubo Rising During COVID-19? Stress, Viral Triggers Need Attention

Infection Risk No Higher With Recycled Pacemakers, Defibrillators

COVID-19: TCTMD’s Daily Dispatch for May

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

COVID-19’s Lopsided Impact on Minorities Should ‘Ignite’ Reform, Experts Say

COVID-19 Linked to 38% Drop in US STEMIs

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH

The Mystery of the Missing STEMIs During the COVID-19 Pandemic

Evinacumab Cuts LDL Cholesterol in Homozygous FH

Inclisiran Data in NEJM Prompt Talk of What Comes Next

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content